KLRF1 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with KLRF1 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with KLRF1 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with KLRF1 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KLRF1 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000142546 - nitric oxide synthase interacting protein

Gene

ENSG00000104894 - CD37 molecule

Gene

ENSG00000087250 - metallothionein 3

Gene

ENSG00000175600 - succinyl-CoA:glutarate-CoA transferase

Gene

ENSG00000166595 - cytosolic iron-sulfur assembly component 2B

Gene

ENSG00000134809 - translocase of inner mitochondrial membrane 10

Gene

ENSG00000110801 - proteasome 26S subunit, non-ATPase 9

Gene

ENSG00000104903 - LYL1 basic helix-loop-helix family member

  • Gene

    ENSG00000142546 - nitric oxide synthase interacting protein


  • Gene

    ENSG00000104894 - CD37 molecule


  • Gene

    ENSG00000087250 - metallothionein 3


  • Gene

    ENSG00000175600 - succinyl-CoA:glutarate-CoA transferase


  • Gene

    ENSG00000166595 - cytosolic iron-sulfur assembly component 2B


  • Gene

    ENSG00000134809 - translocase of inner mitochondrial membrane 10


  • Gene

    ENSG00000110801 - proteasome 26S subunit, non-ATPase 9


  • Gene

    ENSG00000104903 - LYL1 basic helix-loop-helix family member

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.